BioElectronics Corporation (BIEL)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 16.62 Million USD | 3.85% |
| 2022 | 16 Million USD | 5.29% |
| 2021 | 15.2 Million USD | -2.22% |
| 2020 | 15.54 Million USD | 4.21% |
| 2019 | 14.91 Million USD | 10.58% |
| 2018 | 13.49 Million USD | 20.6% |
| 2017 | 11.18 Million USD | 6.8% |
| 2016 | 10.47 Million USD | 6.28% |
| 2015 | 9.85 Million USD | 11.49% |
| 2014 | 8.84 Million USD | 4.86% |
| 2013 | 8.43 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q2 | - USD | -100.0% |
| 2023 Q1 | 16.13 Million USD | 0.81% |
| 2023 FY | 16.62 Million USD | 3.85% |
| 2023 Q3 | - USD | 0.0% |
| 2022 Q1 | 15.32 Million USD | 0.78% |
| 2022 FY | 16 Million USD | 5.29% |
| 2022 Q4 | 16 Million USD | 1.92% |
| 2022 Q3 | 15.7 Million USD | 2.09% |
| 2022 Q2 | 15.38 Million USD | 0.41% |
| 2021 Q3 | 15.69 Million USD | -1.32% |
| 2021 FY | 15.2 Million USD | -2.22% |
| 2021 Q4 | 15.2 Million USD | -3.15% |
| 2021 Q1 | 15.56 Million USD | 0.14% |
| 2021 Q2 | 15.9 Million USD | 2.16% |
| 2020 Q4 | 15.54 Million USD | 0.0% |
| 2020 Q2 | 15.3 Million USD | -0.03% |
| 2020 Q1 | 15.31 Million USD | 2.63% |
| 2020 FY | 15.54 Million USD | 4.21% |
| 2019 Q4 | 14.91 Million USD | 2.48% |
| 2019 Q3 | 14.55 Million USD | 3.26% |
| 2019 Q2 | 14.09 Million USD | 3.4% |
| 2019 FY | 14.91 Million USD | 10.58% |
| 2019 Q1 | 13.63 Million USD | 1.06% |
| 2018 Q2 | 12.5 Million USD | 7.83% |
| 2018 Q1 | 11.59 Million USD | 3.64% |
| 2018 FY | 13.49 Million USD | 20.6% |
| 2018 Q4 | 13.49 Million USD | 3.92% |
| 2018 Q3 | 12.98 Million USD | 3.84% |
| 2017 Q2 | 10.81 Million USD | 3.49% |
| 2017 Q4 | 11.18 Million USD | 0.0% |
| 2017 FY | 11.18 Million USD | 6.8% |
| 2017 Q1 | 10.44 Million USD | -0.25% |
| 2016 Q1 | 10.1 Million USD | 2.48% |
| 2016 FY | 10.47 Million USD | 6.28% |
| 2016 Q2 | 10.45 Million USD | 3.52% |
| 2016 Q4 | 10.47 Million USD | -0.11% |
| 2016 Q3 | 10.48 Million USD | 0.29% |
| 2015 FY | 9.85 Million USD | 11.49% |
| 2015 Q4 | 9.85 Million USD | 1.69% |
| 2015 Q3 | 9.69 Million USD | 2.16% |
| 2015 Q2 | 9.48 Million USD | 3.9% |
| 2015 Q1 | 9.13 Million USD | 3.29% |
| 2014 Q2 | 8.17 Million USD | -1.89% |
| 2014 Q1 | 8.32 Million USD | -1.21% |
| 2014 FY | 8.84 Million USD | 4.86% |
| 2014 Q4 | 8.84 Million USD | 5.09% |
| 2014 Q3 | 8.41 Million USD | 2.94% |
| 2013 Q3 | 8.03 Million USD | 6.32% |
| 2013 Q4 | 8.43 Million USD | 4.89% |
| 2013 FY | 8.43 Million USD | 0.0% |
| 2013 Q2 | 7.56 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Avitar, Inc. | 11.59 Million USD | -43.38% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | 634 Thousand USD | -2521.894% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -2353.131% |
| Polarean Imaging plc | 2.58 Million USD | -544.16% |
| AVITA Medical, Inc. | 19.86 Million USD | 16.323% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | -684.835% |
| Össur hf. | 688.8 Million USD | 97.587% |
| Zecotek Photonics Inc. | 5.86 Million USD | -183.25% |
| QHSLab, Inc. | 2.05 Million USD | -708.09% |
| Wellstar International, Inc. | 55.99 Million USD | 70.311% |
| Össur hf. | 688.8 Million USD | 97.587% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | -3.372% |
| Escalon Medical Corp. | 2.94 Million USD | -463.802% |
| Aurora Spine Corporation | 6.65 Million USD | -149.834% |
| BrainsWay Ltd. | 15.31 Million USD | -8.546% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 6.01 Million USD | -176.464% |
| Hamilton Thorne Ltd. | 45.84 Million USD | 63.74% |
| Vivos Inc. | 245 Thousand USD | -6684.708% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 99.331% |
| Kelyniam Global, Inc. | 1.01 Million USD | -1541.054% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -5931.191% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | -578.535% |
| Nanomix Corporation | 14.81 Million USD | -12.204% |
| Theraclion SA | 13.01 Million EUR | -27.705% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 5.12 Million USD | -224.398% |
| Positron Corporation | 2.02 Million USD | -720.475% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | -359.045% |
| Lombard Medical, Inc. | 53.79 Million USD | 69.099% |
| ALR Technologies Inc. | 24.5 Million USD | 32.167% |
| Stratec SE | 271.97 Million USD | 93.888% |
| Vycor Medical, Inc. | 4.31 Million USD | -284.986% |
| Heart Tronics, Inc. | 1.09 Million USD | -1418.357% |
| Nu-Med Plus, Inc. | 2.35 Million USD | -604.719% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | -203.526% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 74.658% |
| VMS Rehab Systems, Inc. | 201.36 USD | -8255167.68% |
| Guided Therapeutics, Inc. | 5.47 Million USD | -203.613% |
| Ingen Technologies, Inc. | 5.7 Million USD | -191.141% |
| Odyssey Group International, Inc. | 6.61 Million USD | -151.414% |
| United American Healthcare Corporation | 119 Thousand USD | -13868.745% |
| ECGI Holdings, Inc. | 11.94 Million USD | -39.215% |
| Capital Group Holdings, Inc. | 1.32 Million USD | -1155.514% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | -1049.304% |
| Urologix, Inc. | 12.64 Million USD | -31.468% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | -208.054% |
| Nexeon MedSystems Inc. | 8.48 Million USD | -95.967% |
| SS Innovations International, Inc. | 11.18 Million USD | -48.669% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -3063.917% |
| Smith & Nephew plc | 4.76 Billion USD | 99.651% |
| NIOX Group Plc | 9.8 Million USD | -69.584% |
| Fuse Medical, Inc. | 15.11 Million USD | -10.011% |
| Broncus Holding Corporation | 10.43 Million USD | -59.342% |
| Brain Scientific Inc. | 7.42 Million USD | -123.834% |
| Pressure BioSciences, Inc. | 33.8 Million USD | 50.825% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -1993.339% |